The Brain NGF Metabolic Pathway in Health and in Alzheimer’s Pathology
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Brain NGF Metabolic Pathway in Health and in Alzheimer’s Pathology
Authors
Keywords
-
Journal
Frontiers in Neuroscience
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-02-12
DOI
10.3389/fnins.2019.00062
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AF710B, an M1/sigma-1 receptor agonist with long-lasting disease-modifying properties in a transgenic rat model of Alzheimer's disease
- (2018) Hélène Hall et al. Alzheimers & Dementia
- The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
- (2018) Harald Hampel et al. BRAIN
- Muscarinic and nicotinic acetylcholine receptor agonists: current scenario in Alzheimer's disease therapy
- (2018) Stuti Verma et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Compromise of cortical proNGF maturation causes selective retrograde atrophy in cholinergic nucleus basalis neurons
- (2018) Simon Allard et al. NEUROBIOLOGY OF AGING
- Anticholinergic drugs and dementia in older adults
- (2018) Shelly L Gray et al. BMJ-British Medical Journal
- Longitudinal Alzheimer’s Degeneration Reflects the Spatial Topography of Cholinergic Basal Forebrain Projections
- (2018) Taylor W. Schmitz et al. Cell Reports
- Anticholinergic drugs and dementia in older adults
- (2018) Shelly L Gray et al. BMJ-British Medical Journal
- A review of clinical treatment considerations of donepezil in severe Alzheimer's disease
- (2018) Aida Adlimoghaddam et al. CNS Neuroscience & Therapeutics
- Brain Changes in Alzheimer's Disease Patients with Implanted Encapsulated Cells Releasing Nerve Growth Factor
- (2018) Daniel Ferreira et al. JOURNAL OF ALZHEIMERS DISEASE
- Basal Forebrain Volume, but Not Hippocampal Volume, Is a Predictor of Global Cognitive Decline in Patients With Alzheimer's Disease Treated With Cholinesterase Inhibitors
- (2018) Stefan J. Teipel et al. Frontiers in Neurology
- Differential deregulation of NGF and BDNF neurotrophins in a transgenic rat model of Alzheimer's disease
- (2017) M. Florencia Iulita et al. NEUROBIOLOGY OF DISEASE
- Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer’s disease
- (2017) Enrica Cavedo et al. Scientific Reports
- An inflammatory and trophic disconnect biomarker profile revealed in Down syndrome plasma: Relation to cognitive decline and longitudinal evaluation
- (2016) M. Florencia Iulita et al. Alzheimers & Dementia
- A Link Between Nerve Growth Factor Metabolic Deregulation and Amyloid-β-Driven Inflammation in Down Syndrome
- (2016) Maria Florencia Iulita et al. CNS & Neurological Disorders-Drug Targets
- Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer’s Disease
- (2016) Enrica Cavedo et al. JOURNAL OF CLINICAL PSYCHIATRY
- Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer’s pathology
- (2016) Taylor W. Schmitz et al. Nature Communications
- Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer’s disease patients: application of a second-generation encapsulated cell biodelivery device
- (2016) Helga Eyjolfsdottir et al. Alzheimers Research & Therapy
- Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults
- (2016) Shannon L. Risacher et al. JAMA Neurology
- Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease
- (2015) Bruno Dubois et al. Alzheimers & Dementia
- Disruption of cholinergic neurotransmission unmasks aß-related cognitive impairment in preclinical Alzheimer’s disease
- (2015) Peter J. Snyder et al. Alzheimers & Dementia
- Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease
- (2015) Azadeh Karami et al. Alzheimers & Dementia
- The NGF Metabolic Pathway in the CNS and its Dysregulation in Down Syndrome and Alzheimer's Disease
- (2015) M. Florencia Iulita et al. Current Alzheimer Research
- Nerve Growth Factor Gene Therapy
- (2015) Mark H. Tuszynski et al. JAMA Neurology
- Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease
- (2015) Georg M Kerbler et al. NeuroImage-Clinical
- Microdosing of scopolamine as a “cognitive stress test”: Rationale and test of a very low dose in an at-risk cohort of older adults
- (2014) Peter J. Snyder et al. Alzheimers & Dementia
- A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease
- (2014) Michael S. Rafii et al. Alzheimers & Dementia
- Nerve growth factor metabolic dysfunction in Down’s syndrome brains
- (2014) M. Florencia Iulita et al. BRAIN
- LIM Homeobox 8 (Lhx8) Is a Key Regulator of the Cholinergic Neuronal Function via a Tropomyosin Receptor Kinase A (TrkA)-mediated Positive Feedback Loop
- (2013) Takeyasu Tomioka et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Encapsulated Cell Biodelivery of Nerve Growth Factor to the Basal Forebrain in Patients with Alzheimer’s Disease
- (2012) Maria Eriksdotter-Jönhagen et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Impact of the NGF Maturation and Degradation Pathway on the Cortical Cholinergic System Phenotype
- (2012) S. Allard et al. JOURNAL OF NEUROSCIENCE
- Cholinergic modulation of amyloid precursor protein processing with emphasis on M1 muscarinic receptor: perspectives and challenges in treatment of Alzheimer’s disease
- (2011) Abraham Fisher JOURNAL OF NEUROCHEMISTRY
- Anticholinergic drug use and risk for dementia: target for dementia prevention
- (2010) Frank Jessen et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Reduction of Basal Forebrain Cholinergic System Parallels Cognitive Impairment in Patients at High Risk of Developing Alzheimer's Disease
- (2009) M. Grothe et al. CEREBRAL CORTEX
- Amyloid β-Induced Nerve Growth Factor Dysmetabolism in Alzheimer Disease
- (2009) Martin A. Bruno et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Increased Matrix Metalloproteinase 9 Activity in Mild Cognitive Impairment
- (2009) Martin A. Bruno et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now